Form 4: Regeneron Pharmaceuticals VP Controller Jason Pitofsky Reports Stock Disposal
SEC Form 4
Jason Pitofsky, VP Controller at Regeneron Pharmaceuticals, reports the disposal of 298 shares of common stock to cover tax obligations.
Summary
- On December 16, 2024, Jason Pitofsky, VP Controller of Regeneron Pharmaceuticals, disposed of 298 shares of common stock.
- The transaction was executed at a price of $730.81 per share.
- Following the transaction, Pitofsky directly owns 4,664 shares of Regeneron common stock.
- Pitofsky also indirectly owns 11 shares through a 401(k) plan and 179 shares through a trust.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock disposal for tax purposes, so it doesn't significantly impact sentiment.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This allows investors to monitor the actions of those with privileged information.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a small percentage of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 12/16/2024 | Date of stock disposal transaction |
| 12/18/2024 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.